• Masimo (Irvine, California) reported that noninvasive carboxyhemoglobin (SpCO) and methemoglobin (SpMet) will have CPT coding and pricing under the 2009 Medicare Clinical Laboratory Fee Schedule, effective Jan. 1. The new codes will allow healthcare providers to bill and receive up to $7.33 a day when testing eligible patients, the company said. Masimo develops monitoring technologies designed to improve patient care.

• OptumHealth (Golden Valley, Minnesota) said that it is providing a free personal health record (PHR) that is portable and can be shared with physicians, family member or others. The PHR is available through the web site www.myOptumHealth.com. Individuals can now transfer their PHR information from an OptumHealth–managed health portal directly into a Microsoft HealthVault account, which is a security–enhanced, Web–based consumer health platform. Information stored in HealthVault will be "portable" in that it will be available to members even if they change jobs or health plans. OptumHealth manages for employers and health plans, including UnitedHealthcare's myUHC.com. It enables individuals to store, maintain and retrieve their comprehensive health history in a secure and central location.

• Rosetta Genomics (Rehovot, Israel) reported the introduction of its third diagnostic test, miRview meso. miRview meso differentiates mesothelioma, a cancer connected to asbestos exposure, from other carcinomas in the lung. Currently, there is no single diagnostic test that is entirely conclusive for this differentiation. Each year, roughly 130,000 patients in the U.S. are diagnosed with adenocarcinoma of the lung. Malignant pleural mesothelioma is directly linked to exposure to asbestos particles, as well as to various heavy metals. Rescue workers, shipyard workers, and miners are at increased risk of developing mesothelioma. Currently, there is no single diagnostic test that is entirely conclusive for this differentiation.